Lineage Cell Therapeutics (LCTX) Price to Book (2010 - 2026)
Lineage Cell Therapeutics' (LCTX) Price to Book came in at 5.44 for Q2 2026, up 23.3% from 4.41 a year earlier but down 27.2% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Price to Book (2010 - 2026) Analysis & Trends
For FY2025, Lineage Cell Therapeutics' Price to Book stood at 9.11, up 536.9% from FY2024.
- In prior years, Lineage Cell Therapeutics' Price to Book was 1.43 in FY2024 (-53.5%), 3.08 in FY2023 (+11.2%), 2.77 in FY2022 (-39.4%) and 4.57 in FY2021 (+64.8%).
- Quarterly Price to Book has run from a low of 1.32 in Q1 2025 to a high of 17.66 in Q3 2025 over five years.
- On a year-over-year basis, Price to Book has increased in each of the last five quarters, with growth averaging 189.1% over the last eight quarters.
- The strongest year-over-year quarter for Price to Book in the past five years was Q3 2025, with growth of 565.9%; the weakest was Q1 2025, with a decline of 66.4%.
- According to Business Quant data, Price to Book for the three prior quarters was 7.47 (Q1 2026), 9.11 (Q4 2025) and 17.66 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Lineage Cell Therapeutics | 240.26 Mn | 38.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.44 |
| Mar 31, 2026 | 7.47 |
| Dec 31, 2025 | 9.11 |
| Sep 30, 2025 | 17.66 |
| Jun 30, 2025 | 4.41 |
| Mar 31, 2025 | 1.32 |
| Dec 31, 2024 | 1.43 |
| Sep 30, 2024 | 2.65 |
| Jun 30, 2024 | 2.82 |
| Mar 31, 2024 | 3.94 |
| Dec 31, 2023 | 3.08 |
| Sep 30, 2023 | 3.10 |
| Jun 30, 2023 | 3.45 |
| Mar 31, 2023 | 3.70 |
| Dec 31, 2022 | 2.77 |
| Sep 30, 2022 | 2.48 |
| Jun 30, 2022 | 3.29 |
| Mar 31, 2022 | 3.07 |
| Dec 31, 2021 | 4.57 |
| Sep 30, 2021 | 3.55 |
API Access
Lineage Cell Therapeutics Price to Book API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-book&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-book", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-book&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();